Mealtime inhaled insulin lowers fasting glucose: a look at possible explanations

被引：3

作者：

DeVries, JH ^{[1
]}

机构：

[1] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1100 DD Amsterdam, Netherlands

来源：

DIABETOLOGIA | 2005年 / 48卷 / 12期

关键词：

D O I：

10.1007/s00125-005-0027-0

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2682 / 2683

页数：2

共 11 条

[1] Assessment of insulin levels and comparison to subcutaneous injection [J].

Cherrington, AD ;

Neal, DW ;

Edgerton, DS ;

Glass, D ;

Bowen, L ;

Hobbs, CH ;

Leach, C ;

Rosskamp, R ;

Strack, TR .

DIABETES, 2004, 53 (04) :877-881

[2] Improved glycaemic control in type 1 diabetes patients following participation per se in a clinical trial -: mechanisms and implications [J].

DeVries, JH ;

Snoek, FJ ;

Kostense, PJ ;

Heine, RJ .

DIABETES-METABOLISM RESEARCH AND REVIEWS, 2003, 19 (05) :357-362

[3] Inhalation of insulin (Exubera) is associated with augmented disposal of portally infused glucose in dogs [J].

Edgerton, DS ;

Neal, DW ;

Scott, M ;

Bowen, L ;

Wilson, W ;

Hobbs, CH ;

Leach, C ;

Sivakumaran, S ;

Strack, TR ;

Cherrington, AD .

DIABETES, 2005, 54 (04) :1164-1170

[4] Antibody response to inhaled insulin in patients with type 1 or type 2 diabetes. An analysis of initial phase II and III inhaled insulin (Exubera) trials and a two-year extension trial [J].

Fineberg, SE ;

Kawabata, T ;

Finco-Kent, D ;

Liu, C ;

Krasner, A .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (06) :3287-3294

[5] Intensive therapy with inhaled insulin via the AERx insulin diabetes management system [J].

Hermansen, K ;

Rönnemaa, T ;

Petersen, AH ;

Bellaire, S ;

Adamson, U .

DIABETES CARE, 2004, 27 (01) :162-167

[6]

JEANDIDIER N, 1995, DIABETOLOGIA, V38, P577, DOI 10.1007/s001250050322

[7] INSULIN ANTIBODY-RESPONSES AFTER LONG-TERM INTRAPERITONEAL INSULIN ADMINISTRATION VIA IMPLANTABLE PROGRAMMABLE INSULIN DELIVERY SYSTEMS [J].

OLSEN, CL ;

CHAN, E ;

TURNER, DS ;

IRAVANI, M ;

NAGY, M ;

SELAM, JL ;

WONG, ND ;

WAXMAN, K ;

CHARLES, MA .

DIABETES CARE, 1994, 17 (03) :169-176

[8] Efficacy and safety of inhaled insulin (exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes -: Results of a 6-month, randomized, comparative trial [J].

Quattrin, T ;

Bélanger, A ;

Bohannon, NJV ;

Schwartz, SL .

DIABETES CARE, 2004, 27 (11) :2622-2627

[9] Time-action profile of inhaled insulin in comparison with subcutaneously injected insulin lispro and regular human insulin [J].

Rave, K ;

Bott, S ;

Heinemann, L ;

Sha, S ;

Becker, RHA ;

Willavize, SA ;

Heise, T .

DIABETES CARE, 2005, 28 (05) :1077-1082

[10] Meta-analysis of short-acting insulin analogues in adult patients with type 1 diabetes: continuous subcutaneous insulin infusion versus injection therapy [J].

Siebenhofer, A ;

Plank, J ;

Berghold, A ;

Horvath, K ;

Sawicki, PT ;

Beck, P ;

Pieber, TR .

DIABETOLOGIA, 2004, 47 (11) :1895-1905

← 1 2 →